Latest news with #Amruth
Yahoo
22-05-2025
- Business
- Yahoo
India Glycols Ltd (BOM:500201) Q4 2025 Earnings Call Highlights: Strong Biofuels Growth Amidst ...
Release Date: May 21, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. India Glycols Ltd (BOM:500201) reported a strong growth in biofuels, with a 48% increase in revenue to 273 crores. The company achieved a significant improvement in EBITDA margin, rising to 17.1% from 11.7% year-on-year. The portable spirit segment saw a notable increase in margins from 16.2% to 27%, indicating strong performance. The joint venture showed a remarkable improvement, with net profit share increasing nearly threefold. India Glycols Ltd (BOM:500201) has successfully expanded its product portfolio in the premium liquor segment through a partnership with Amruth, enhancing its market presence. The net revenue for Q4 2025 saw a marginal decline compared to the previous year, indicating some challenges in maintaining top-line growth. The bio-based specialty chemicals segment experienced a softer quarter with a 17.6% decline in net revenue. The nutraceutical and biopharma segment faced significant pricing pressure due to increased competition and softer international demand. The chemical business reported stagnant growth, with some core segments underperforming. Despite overall growth, the company faces challenges in maintaining profitability in the joint venture due to fluctuating crude prices and associated costs. Warning! GuruFocus has detected 9 Warning Signs with BOM:500201. Q: Given the market is well supplied, is the margin profile for the In Nature Pharma segment expected to be lower than historically? A: (CEO) The market and organization are in transition. We are moving up the value chain with efforts like receiving an establishment inspection report with no observations from the FDA. We are focusing on branded products and demonstrating differentiation in product performance and quality standards. While challenges exist, we have a clear plan to move into higher value spaces, and the business fundamentals remain strong. Q: With crude prices sliding back, how do you foresee the joint venture's performance in the future? A: (CEO) The difference between IPO price and market price has decreased, and we don't expect it to return to previous high levels. We've taken actions to mitigate risks, such as investing in grain-based capacity and diversifying products. The joint venture is more established now, focusing on indigenization and improved product mix, which should help manage pressures. Q: Is the high EBIT margin in the spirits division sustainable in the coming years? A: (CEO) Structurally, we don't see anything that would drastically reduce margins. While there are occasional variations in costs, we are focusing on premiumization and moving up the value chain. There are no immediate red flags suggesting a significant margin decline. Q: What is the return on capital for the spirits business? A: (CFO) The return on capital for the spirits business is around 17 to 18%. Q: How will the debt be allocated between the chemical and liquor divisions post-merger? A: (CFO) Out of the total long-term debt of about 1,200 crores, 500 crores will go to the chemical division and 700 crores to the liquor division. The repayment schedule includes about 150 to 160 crores annually for the liquor division and about 90 crores for the chemical division. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
The Hindu
03-05-2025
- Health
- The Hindu
Rotary Club of Visakhapatnam with Andhra Pradesh MedTech Zone organises Samajikam 2025
Rotary Club of Visakhapatnam in collaboration with the Andhra Pradesh MedTech Zone (AMTZ) organised Samajikam 2025 with the theme of 'Empowering Communities Through CSR,' here on Saturday. AMTZ founder CEO and MD Jitendra Sharma inaugurated the event. He said, 'Both AMTZ and Rotary are built on the foundation of service— one through healthcare innovation, and the other through humanitarian action. This partnership is a strategic convergence. Our assistive technology centre, community health initiatives and Made in India hospitals are the instruments of empowerment. Together with Rotary's 120-year legacy and AMTZ's vibrant innovations, we can scale social impact and transform lives across the world.' Rotary's district governor, M. Venkateswara Rao, said, 'With 1.4 million rotarians globally and deep-rooted grassroots presence, Rotary is uniquely positioned to amplify the impact of CSR. Our collaboration with AMTZ—a beacon of indigenous innovation—is a leap toward holistic, tech-enabled social change.' Rotary Club Visakhapatnam also launched 'Amruth,' a flagship CSR initiative to protect adolescent girls from HPV and prevent cervical cancer. Led by Muralikrishna of Mahatma Gandhi Cancer Hospital, the programme has already vaccinated over 1,000 girls.
